Alpha-gal syndrome (AGS) is a tick-triggered allergy to a sugar molecule called galactose-alpha-1,3-galactose, commonly known as alpha-gal. This molecule sits on the surface of cells in nearly all non-primate mammals, including cows, pigs, sheep, deer, and rabbits. Humans don't produce it. That evolutionary quirk is precisely why the immune system can learn to treat it as a threat.
The sensitization happens through a tick bite, not through food. When the lone star tick (Amblyomma americanum) bites, alpha-gal from the tick's saliva is injected directly under the skin. This bypasses the gut's normal tolerance mechanisms and triggers the immune system to produce IgE antibodies against alpha-gal. After that, eating mammal products causes those antibodies to activate, releasing histamine and triggering an allergic reaction.
The most disorienting feature of AGS is the delay. Because alpha-gal is a carbohydrate rather than a protein, digestion is slower. Alpha-gal from a meal reaches the bloodstream several hours after eating, not within minutes. Reactions typically appear 2 to 6 hours after consuming mammal products, and sometimes up to 8 hours later. Many people wake up in the middle of the night covered in hives after a normal dinner and don't connect the dots for months.
AGS is significantly underdiagnosed. The CDC estimates that up to 450,000 Americans may have it. A 2023 MMWR report found that 42% of surveyed US healthcare providers had never heard of AGS. The lone star tick is most common in the south-central and southeastern United States, but its range is expanding into states like New York and Pennsylvania.






